CSC biomarkers that have been identified in HCC, including CD133, CD90, CD44, Nanog, octamer-binding transcription factor 4 (OCT4), and SRY-box transcription factor 2 (SOX2), have been reported to contribute to the maintenance of stemness [10]. This evidence concerns the gene SOX2 and hepatocellular carcinoma.